What is Urologic Oncology?
Urologic Oncology is a branch of Urology that involves the diagnosis and treatment of cancers of the urinary system and male sexual system. The most common urologic cancers are prostate cancer, bladder cancer, kidney cancer, and testis cancer. Urologic cancers are diagnosed in approximately 300,000 Americans each year.
The Urologic Oncologist is trained in the surgical treatment of patients with urologic cancers. The Urologic Oncologist is also a team leader and coordinates care with medical oncologists (who treat cancer with chemotherapy), radiation oncologists (who treat cancer with radiation therapy), and support services such as neuropsychology, enterostomal care, social service, home health care, and complementary medicine. When appropriate, patients are offered entry into clinical trials.
The outcome from treatment for cancer depends upon the type of cancer (where the cancer originated), the grade (how rapidly the cancer progresses), and the stage (how far the cancer has progressed). At CCSI, we have a treatment option available for every grade and stage of every type of urologic cancer. Management options can range from active surveillance (such as in men with low grade and stage prostate cancer and patients with small kidney tumors) to a multi-modal approach (such as surgery, chemotherapy, and radiation in patients with advanced bladder cancer). We have 12 National Cancer Institute supported clinical trials currently open in bladder, prostate, and kidney cancer.
Our goal in Urologic Oncology at CCSI is to provide personalized, comprehensive care for patients with urologic cancers using state-of-the-art equipment and treatment options.